Neuronal vulnerability, pathogenesis, and Parkinson's disease
about
The role of oxidative stress in Parkinson's diseaseSystematic mutagenesis of α-synuclein reveals distinct sequence requirements for physiological and pathological activitiesThe Response to Oxidative DNA Damage in Neurons: Mechanisms and DiseaseAldehyde Dehydrogenase 1 making molecular inroads into the differential vulnerability of nigrostriatal dopaminergic neuron subtypes in Parkinson's diseaseCell-permeable parkin proteins suppress Parkinson disease-associated phenotypes in cultured cells and animalsPropagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.Wnt/β-catenin signaling in midbrain dopaminergic neuron specification and neurogenesis.PPARγ as a therapeutic target to rescue mitochondrial function in neurological diseaseConverging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's diseaseNeuroimaging of Parkinson's disease: Expanding views.Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expressionCharacterization of Differentiated SH-SY5Y as Neuronal Screening Model Reveals Increased Oxidative VulnerabilityAldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulationSomatic alpha-synuclein mutations in Parkinson's disease: hypothesis and preliminary data.Connectivity Changes in Parkinson's Disease.Brain Magnetic Resonance Imaging (MRI) as a Potential Biomarker for Parkinson's Disease (PD).Aldehyde dehydrogenase 1-positive nigrostriatal dopaminergic fibers exhibit distinct projection pattern and dopamine release dynamics at mouse dorsal striatum.Development-inspired reprogramming of the mammalian central nervous system.Generation of a neuro-specific microarray reveals novel differentially expressed noncoding RNAs in mouse models for neurodegenerative diseasesPlatelet mitochondrial membrane potential in Parkinson's disease.Presynaptic effects of levodopa and their possible role in dyskinesia.Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state.Changes in neuronal dopamine homeostasis following 1-methyl-4-phenylpyridinium (MPP+) exposure.Glial Expression of the Caenorhabditis elegans Gene swip-10 Supports Glutamate Dependent Control of Extrasynaptic Dopamine SignalingDopamine-dependent corticostriatal synaptic filtering regulates sensorimotor behavior.Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.Bent out of shape: α-Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease.Cav 1.3 (CACNA1D) L-type Ca(2+) channel dysfunction in CNS disordersIntranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammationReshaping the brain: direct lineage conversion in the nervous system.Selective vulnerability to neurodegenerative disease: the curious case of Prion Protein.Dicer expression is essential for adult midbrain dopaminergic neuron maintenance and survival.The hallmarks of Parkinson's disease.Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF.α-Synucleinopathy in the Human Amygdala in Parkinson Disease: Differential Vulnerability of Somatostatin- and Parvalbumin-Expressing Neurons.Computer-based magnetic resonance imaging as a tool in clinical diagnosis in neurodegenerative diseases.Calcium and Parkinson's disease.Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADY-PD).LRRKing up the right trees? On figuring out the effects of mutant LRRK2 and other Parkinson's disease-related genes.Compensatory T-type Ca2+ channel activity alters D2-autoreceptor responses of Substantia nigra dopamine neurons from Cav1.3 L-type Ca2+ channel KO mice.
P2860
Q24307946-5B36F53B-6CD0-43B0-BF3F-38E844E24135Q26269871-1D8510C2-516E-468E-9146-D91879109D66Q26768287-8A8202FB-9463-4B71-9989-21A969A4E255Q26850502-FB37CB36-AFE3-4D55-B1A7-1CD60288BB20Q27318797-4295736B-DA88-43C3-984E-46075DA50518Q27322513-F6435C12-C67D-44A5-BAC1-77FAB85AA183Q27692055-7599041C-CF6A-4E5C-8784-723CE5DDB725Q28069549-8DB7281B-B84A-4D64-8CF8-93EBA23FFE70Q28074143-A2087762-5F2B-4A29-8013-C0FC82D65938Q28387732-16B9FBFA-821E-4048-830A-46D37F3B724EQ28598223-91DC3FE8-C1A6-4318-8C9B-01DF2B75D319Q28830540-D1DFE024-B8CE-41B6-8A28-EFDFC73BBF52Q30581658-5709F2BC-5A8A-4DEA-82D3-2340D1F217A8Q30626337-45415154-6368-4194-9D4C-B4D622B13436Q33363796-F78B400A-1DD5-4611-B0D9-8672BFFBB961Q33831798-3D1B4448-BC23-4187-9C42-6F88A257F8AEQ33902847-BA1D30AE-B78C-43DE-852B-41AB4D952408Q34003679-04CDEA79-C582-48E3-B9E0-ACDD46921EC8Q34547209-7E5A0190-8155-4D65-95C5-BCC54A2FCAC4Q34994475-5060EBC9-EED3-44CB-86F1-49F03D1D60B5Q35040280-853C6E8A-3FBD-4206-B10F-23FC9FEAAF3FQ35053448-0B479B04-9CA5-473C-A72C-88175C491283Q35172603-7D05DAEC-B988-48CA-82AA-5B4EEA48FEECQ35772934-C172AD40-8635-4BFB-B1CC-A4DD33D15B49Q35828317-B7D184E3-9808-4408-8630-2AAFF0833B7DQ35834043-5A98836E-7C55-4F44-8632-DE53F60679B7Q36373170-51222805-3FF8-4359-944E-352C57B00564Q36772265-71B42D8A-148E-41F0-AB69-235D92217775Q36813784-83D7EF3C-F1DB-4CB5-AB18-1239CC1F8D0BQ37159009-D2718E5A-2FB7-4EDE-86D5-FD79A4D2986FQ37438476-70D8E8F2-2CE1-4EBE-A965-B8A4F0587816Q37621936-63C53419-BE9E-4A88-BB3C-B637A334A659Q38105645-2A92C72D-F8CE-45EA-A37E-1F3641E86EB0Q38401306-E7098836-C16C-4278-B79F-B6308CC822D4Q38599625-2DE47A07-607E-4EC6-88DF-C8DD47E53175Q38710593-48CFFEE1-E4BF-49FE-806B-BB4DA9A18499Q38945252-D4188947-B7E0-427E-96F2-522BFD11588FQ39333338-BB30873C-3405-4B65-8E46-D465FA58C866Q42971557-98C8BF9B-B9A2-44A8-AF53-AD583C2B676DQ43238317-5F4D7850-282F-4444-8FB5-1B32CC19E05A
P2860
Neuronal vulnerability, pathogenesis, and Parkinson's disease
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Neuronal vulnerability, pathogenesis, and Parkinson's disease
@en
type
label
Neuronal vulnerability, pathogenesis, and Parkinson's disease
@en
prefLabel
Neuronal vulnerability, pathogenesis, and Parkinson's disease
@en
P2860
P356
P1433
P1476
Neuronal vulnerability, pathogenesis, and Parkinson's disease
@en
P2093
D James Surmeier
P2860
P356
10.1002/MDS.25095
P407
P50
P577
2012-07-12T00:00:00Z